Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Hydroxychloroquine Shortage: What About Patients with Autoimmune Disorders?

    According to CNBC, there is a shortage across the country of a very important medication: hydroxychloroquine. This is somewhat unsurprising. After all, the Trump administration has been vocal about the…

    Continue Reading Hydroxychloroquine Shortage: What About Patients with Autoimmune Disorders?
    Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease
    Free-Photos / Pixabay

    Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease

    According to an article in The Asahi Shimbun, Japanese scientists have developed a new vaccine to mitigate neuronal degeneration caused by Alzheimer's disease. The vaccine, delivered nasally, had promising results…

    Continue Reading Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease
    Chemicals Linked to Development of Parkinson’s Disease, Says Dutch Neurologist
    source: pixabay.com

    Chemicals Linked to Development of Parkinson’s Disease, Says Dutch Neurologist

      According to Parkinson's News Today, Dutch neurologist Bastiaan Bloem, MD, believes that the development of Parkinson's disease can be attributed to chemical exposure. About Parkinson's Disease Parkinson's disease is…

    Continue Reading Chemicals Linked to Development of Parkinson’s Disease, Says Dutch Neurologist
    New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
    Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

    New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response

      According to new research from the Journal of Infectious Diseases, a new protein epitope has been discovered while testing the immune response of people with Kawasaki Disease. Kawasaki Disease, also…

    Continue Reading New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
    Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong
    source: pixabay.com

    Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong

      If you're worried or anxious because of COVID-19, you're not alone. If wondering about the intersection of rare diseases and COVID-19 only increases that anxiety, well, we're with you…

    Continue Reading Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong
    Planting Love Around the World: A Young Patient with Neurofibromatosis Works to Reduce COVID-19 Anxiety
    source: pixabay.com

    Planting Love Around the World: A Young Patient with Neurofibromatosis Works to Reduce COVID-19 Anxiety

      According to a story from Wexford People, 8-year-old Mia-Lily Ruttle wants to spread some hope to people around the globe. The girl, who has neurofibromatosis, was upset by the impact…

    Continue Reading Planting Love Around the World: A Young Patient with Neurofibromatosis Works to Reduce COVID-19 Anxiety
    Rivaroxaban Lowers Risk of Venous Thromboembolism for Orthopedic Surgeries as Compared to Heparin
    source: pixabay.com

    Rivaroxaban Lowers Risk of Venous Thromboembolism for Orthopedic Surgeries as Compared to Heparin

      According to a news release from the American College of Cardiology, rivaroxaban is more effective than enoxaprin (heparin) in preventing blood clots or low platelet counts in patients after…

    Continue Reading Rivaroxaban Lowers Risk of Venous Thromboembolism for Orthopedic Surgeries as Compared to Heparin
    BIO-X® Grant Given to Ilya Pharma to Develop Gene Therapy Solutions for Patients with Inflammatory Bowel Disease
    source: pixabay.com

    BIO-X® Grant Given to Ilya Pharma to Develop Gene Therapy Solutions for Patients with Inflammatory Bowel Disease

      According to Microbiome Times, Ilya Pharma has received a BIO-X® grant to study gene therapy for patients with inflammatory bowel disease. Their chemokine-based gene therapy drug candidates seek to…

    Continue Reading BIO-X® Grant Given to Ilya Pharma to Develop Gene Therapy Solutions for Patients with Inflammatory Bowel Disease
    ALUNBRIG Approved by European Commission as Treatment for Patients with ALK+ NSCLC
    kalhh / Pixabay

    ALUNBRIG Approved by European Commission as Treatment for Patients with ALK+ NSCLC

      According to a release on Biospace, the European Commission (EC) has approved Takeda Pharmaceutical's ALUNBRIG (brigatinib) as treatment for patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer…

    Continue Reading ALUNBRIG Approved by European Commission as Treatment for Patients with ALK+ NSCLC
    Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
    Pexels / Pixabay

    Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis

      A news release from Benzinga shares that biotechnology company Emerald Health Pharmaceuticals is beginning a Phase 2 clinical study on EHP-101 as a treatment for patients with systemic sclerosis.…

    Continue Reading Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis

    Intrahepatic Cholestasis of Pregnancy and its Link to Non-Alcoholic Fatty Liver Disease

      According to a study summarized in Gastroenterology Consultant, pregnant women with intrahepatic cholestasis of pregnancy are much more likely to also be diagnosed with nonalcoholic fatty liver disease. You can…

    Continue Reading Intrahepatic Cholestasis of Pregnancy and its Link to Non-Alcoholic Fatty Liver Disease